Swedish-based biopharmaceutical company Hansa Medical plans to acquire the rights to cancer immunotherapy using antibody modulating enzymes, through the acquisition of glycobiology therapeutic antibodies developer Immago Biosystems Ltd.

Immago Biosystems is a spinout company of the University of Oxford.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Specialist pharmaceutical company Knight Therapeutics has acquired an additional 15.8% stake in Canadian-based pharmaceutical company Pediapharm, to become an 18.5% stakeholder of the company.

Upon completion of the transaction, Knight Therapeutics will hold 757,500 warrants that are convertible into common shares of Pediapharm at any time until March 2019.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Imagene’s Oncology Intelligence (OI) Suite has won the Innovation Award for Precision Oncology, for transforming how pharma designs and runs oncology trials. From AI-driven biomarker discovery to smarter patient stratification, see how Imagene is cutting time, cost and risk in cancer drug development.

Discover the Impact